Indomethacin tocolysis and risk of necrotizing enterocolitis

Obstetrics and Gynecology

Volumn 96, Issue 1, 2000, Pages 120-123

  Parilla, Barbara V ^a   A Grobman, William ^a   Holtzman, Ronald B ^a   Thomas, Hope A ^a   Dooley, Sharon L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; INDOMETACIN; MAGNESIUM SULFATE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK; TOCOLYSIS;

ADULT; CASE-CONTROL STUDIES; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; MALE; PREGNANCY; TOCOLYTIC AGENTS;

EID: 0034119290     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00846-2     Document Type: Article

References (14)

1. Zuckerman H., Reiss U., Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol. 44:1974;787-792.
2. Neibyl J.R., Blake D.A., White R.D., Kumor K.M., Dubin N.H., Robinson J.C., et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 135:1980;1014-1019.
3. Morales W.J., Smith W.G., Angel J.L., O'Brien W.F., Knuppel R.A. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor A randomized study . Obstet Gynecol. 74:1989;567-572.
4. Kurki T., Eronen M., Lumme R., Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol. 78:1991;1093-1097.
5. Morales W.J., Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor A randomized study . Am J Obstet Gynecol. 169:1993;97-102.
6. Dudley D.J., Hardie M.B. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol. 151:1985;181-184.
7. Niebyl J.R., Witter F.R. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol. 155:1986;747-749.
8. Moise K.J. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol. 168:1993;1350-1353.
9. Vermillion S.T., Scardo J.A., Lashus A.G., Wiles H.B. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol. 177:1997;256-261.
10. Eronen M., Peronen E., Kurki T., Teramo K., Ylikorkala O., Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr. 124:1994;782-788.
11. Norton M.E., Merrill J., Cooper A.B., Kuller J.A., Clyman R.I. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 329:1993;1602-1607.
12. Major C.A., Lewis D.F., Hardin J.A., Porto M.A., Garite T.J. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol. 170:1994;102-106.
13. Salafia C.M., Minior V.K., Rosenkrantz T.S., Pezzullo J.C., Popek E.J., Cusick W., et al. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks gestation. Am J Perinatol. 12:1995;429-436.
14. Gardner M.O., Owen J., Skelly S., Hauth J.C. Preterm delivery after indomethacin. A risk factor for complications? J Reprod Med. 41:1996;903-906.